Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A new laser technique can precisely remove specific cell types in living animals without harming nearby cells.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Nestin-expressing blood vessels help skin transplants survive and heal.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

CD200 is not a reliable marker for identifying stem cells in all skin types.

MK-5108 is safe and shows potential against tumors, especially alone.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Wnt and Notch pathways are crucial for repairing blood stem cells after damage.

Nilotinib can cause generalized keratosis pilaris.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Autoimmune reactions may cause both alopecia areata and HAM.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.